Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Neuro-Oncology|October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.Cancer Research|June 12, 2013
Posttranscriptional regulation of PER1 underlies the oncogenic function of IREαOlivier Pluquet, Nicolas Dejeans, Marion Bouchecareilh, et al.International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled TrialThomas M Churilla, Karla V Ballman, Paul D Brown, et al.International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.Nature Medicine|September 17, 2013
A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibitionKevin Wei, Stephanie M Piecewicz, Lisa M McGinnis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab TrialEdith A Perez, E Aubrey Thompson, Karla V Ballman, et al.JAMA Oncology|October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical TrialJoshua D Palmer, Brett G Klamer, Karla V Ballman, et al.Plos One|November 14, 2013
An integrated model of the transcriptome of HER2-positive breast cancerKrishna R Kalari, Brian M Necela, Xiaojia Tang, et al.Neuro-Oncology|July 18, 2020
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study designKurt A Jaeckle, Karla V Ballman, Martin van den Bent, et al.Nature|September 17, 2015
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signallingNobuhiko Kayagaki, Irma B Stowe, Bettina L Lee, et al.Pageof 11